Background
==========

L-Cysteine, a sulfur-containing amino acid (SAA), is ubiquitous in virtually all living organisms from bacteria to higher eukaryotes, and plays an essential role in the various cellular processes including stability, structure, regulation of catalytic activity, and posttranslational modification for various proteins. Due to the ability of its thiol group to undergo redox reactions, L-cysteine has antioxidant properties, and is used for the biosynthesis of glutathione, which is found in humans as well as other organisms. In addition, L-cysteine is also essential for the synthesis of trypanothione, coenzyme A, hypotaurine, taurine as well as ubiquitous iron-sulfur (Fe-S) clusters, which are involved in electron transfer, redox regulation, nitrogen fixation, and sensing for regulatory processes \[[@B1]\].

*Entamoeba histolytica*, an enteric protozoan parasite, causes amebic colitis and extra intestinal abscesses in millions of inhabitants of endemic areas, and responsible for thousands of deaths annually \[[@B2]\]. The trophozoites of *E*. *histolytica*primarily reside in the anaerobic environment of the colonic lumen, but are exposed to various reactive oxygen and nitrogen species (ROS and RNS) during tissue invasion, metastasis, and extra intestinal propagation \[[@B2],[@B3]\]. *E. histolytica*lacks most of the components of the eukaryotic oxidative stress defence system including catalase, peroxidase, glutathione, and glutathione-recycling enzymes. However, it possesses alternative mechanisms for detoxification of the reactive oxygen and nitrogen species. The alternative mechanisms are most likely to involve superoxide dismutase (SOD), peroxiredoxin, flavodiiron proteins (FDPs), and reducing agents (thiols), especially L-cysteine \[[@B4]-[@B6]\]

Among a number of metabolic peculiarities, metabolism of SAAs in *E. histolytica*is distinct from that of its mammalian host in a variety of aspects. First, it lacks both forward and reverse trans-sulfuration pathways and thus is unable to interconvert L-methionine and L-cysteine \[[@B6]\] Second, it possesses methionine γ-lyase (MGL) which degrades L-methionine, L-homocysteine, and L-cysteine \[[@B7]-[@B9]\]. Third, *E. histolytica*possesses enzymes for the *de novo*S-methylcysteine/L-cysteine biosynthesis \[[@B10]-[@B12]\]. The S-methylcysteine/L-cysteine biosynthetic pathway involves serine acetyltransferase (SAT, EC2.3.1.30) that catalyzes acetyl CoA-dependent acetylation of the side chain hydroxyl group of L-serine to form O-acetylserine (OAS) \[[@B13]\]. Subsequently, cysteine synthase \[(CS; OAS (thiol) lyase; EC4.2.99.8)\] catalyzes the reaction of OAS with methanethiol or sulfide to produce S-methylcysteine or L-cysteine, respectively. Recombinant amebic CS isotypes possess both S-methylcysteine and L-cysteine synthesizing activities *in vitro*. However, our recent *in vivo*study \[[@B12]\] revealed that CS isotypes are primarily involved in the synthesis of SMC, but not of L-cysteine. Since, this pathway is not involved in the synthesis of L-cysteine, *in vitro*cultivation of amebic trophozoites requires high concentrations of L-cysteine, and this requirement can not be replaced by other thiols \[[@B14]\]. In *E. histolytica*, L-cysteine is required for the growth, attachment, survival, and protection from oxidative stress \[[@B14],[@B15]\].

All prokaryotic and eukaryotic cells are known to have an ability to restructure their transcriptomes in order to adapt to the environmental conditions by sensing the endogenous level of various metabolites. Small-molecule metabolites, including amino acids, nucleotides, and carbohydrates have been shown to regulate the expression of large number of genes at the transcriptional and post-transcriptional levels \[[@B16]\]. In addition, intracellular redox determined by various metabolites has also been demonstrated to be an important regulator to gene expression \[[@B16]\].

In most eukaryotes, glutathione is the major thiol, and L-cysteine levels are maintained many fold lower than that of glutathione \[[@B17]\]. However, *E. histolytica*completely lacks glutathione metabolism and relies on L-cysteine as a major redox buffer \[5, 6, and 8\]. Therefore, *E. histolytica*represents an excellent model to study the effect of L-cysteine deprivation on gene expression and cellular metabolism. Our recent metabolomic study demonstrated that in *E. histolytica*, L-cysteine regulates various metabolic pathways, including energy, amino acid, and phospholipid metabolism \[[@B12]\]. In this study we performed DNA microarray analysis of gene expression in *E. histolytica*cultured in L-cysteine-deprived conditions. We found that the expression of a large number of genes was modulated in response to the L-cysteine deprivation.

Results and Discussions
=======================

L-Cysteine deprivation induces global changes in the gene expression
--------------------------------------------------------------------

To better understand the role of L-cysteine in transcriptional regulation of gene expression in *E. histolytica*, we performed time course analysis of genome wide gene expression upon L-cysteine deprivation, using a custom-made Affymetrix microarray representing 9,327 of *E. histolytica*genes. We identified 290 genes (3.1%) modulated by at least 3 fold (p-value \< 0.05) at one or more time points in response to L-cysteine deprivation (Additional file [1](#S1){ref-type="supplementary-material"}). Out of them, 129 genes were up-regulated and 167 genes were down-regulated, while 6 genes showed both up- and down-regulation depending upon the time points (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}; Additional files [2](#S2){ref-type="supplementary-material"} and [3](#S3){ref-type="supplementary-material"}). Out of the 129 up-regulated genes, 51 genes (40%) were assigned with putative biological functions, namely signalling, general metabolism, lipid metabolism, DNA/RNA regulation, electron transport, stress response, transport, and trafficking/secretion/cytoskeleton (Figure [1](#F1){ref-type="fig"}). The remaining 78 genes (60%) were categorized into genes encoding either hypothetical proteins without (68) or with known conserved domain(s) (10). A total of 167 genes were down regulated by ≥3 fold at one or more time points upon L-cysteine deprivation, 108 (65%) of which encode hypothetical proteins or hypothetical proteins containing conserved domain(s), whereas remaining 59 genes (35%) encode proteins with putative biological functions (Figure [1](#F1){ref-type="fig"}).

###### 

List of most highly induced genes upon L-cysteine deprivation

  Probe set ID       Accession numbers   Common Names                                      Basal Expression (log~2~)   3 h      6 h       12 h      24 h     48 h     p value
  ------------------ ------------------- ------------------------------------------------- --------------------------- -------- --------- --------- -------- -------- ---------
  EHI_173950_at      XM_647419           Major facilitator superfamily (MFS) transporter   6.11                        \+ 4.1   \+ 14.6   \+ 10.0   \+ 4.7   \+ 2.6   3.0E-07
  EHI_138480_at      XM_650038           Iron-sulfur flavoprotein, putative                8.40                        \+ 3.6   \+ 6.8    \+ 9.8    \+ 5.4   \+ 4.2   4.5E-08
  EHI_025710_at      XM_644279           Iron-sulfur flavoprotein, putative                7.17                        \+ 3.6   \+ 5.4    \+ 8.7    \+ 5.2   \+ 3.9   1.0E-06
  13.m00350_at       XM_651312           Hypothetical protein                              2.73                        \- 1.0   \+ 2.4    \+ 7.8    \+ 5.4   \+ 6.5   2.4E-04
  EHI_176810_at      XM_644746           Hypothetical protein                              3.53                        \+ 4.8   \+ 8.8    \+ 6.0    \+ 1.2   \- 1.3   4.6E-04
  EHI_130490_at      XM_643338           Hypothetical protein                              7.42                        \+ 1.7   \+ 1.9    \+ 5.8    \+ 3.5   \+ 1.7   1.8E-05
  EHI_091050_at      XM_645468           Zinc finger protein, putative (IBR superfamily)   5.39                        \+ 2.9   \+ 9.1    \+ 5.7    \- 1.4   \- 1.7   1.3E-06
  EHI_080280_at      XM_644430           Glu6-phosphate N-acetyltransferase. putative      3.79                        \+ 8.6   \+ 6.2    \+ 5.5    \+ 1.3   \- 1.3   3.3E-05
  EHI_032670_s\_at   XM_645799           Iron sulfur flavoprotein like, putative           7.47                        \+ 1.5   \+ 3.5    \+ 5.4    \+ 3.9   \+ 4.0   3.4E-06
  870.m00013_x\_at   XM_642792           Hypothetical protein                              2.54                        \+ 3.4   \+ 6.4    \+ 5.0    \+ 1.3   \+ 1.9   6.5E-04
  EHI_096770_at      XM_650580           Acetyltransferase, putative                       7.01                        \+ 1.9   \+ 3.4    \+ 4.8    \+ 3.7   \+ 4.2   4.9E-05
  EHI_137260_at      XM_647486           Hypothetical protein                              2.97                        \+ 3.7   \+ 4.4    \+ 4.8    \+ 2.4   \+ 2.6   2.0E-03
  65.m00145_x\_at    XM_648920           Hypothetical protein                              3.08                        \+ 1.2   \+ 3.3    \+ 4.7    \+ 1.1   \- 1.6   6.1E-06
  EHI_062300_at      XM_645096           Hypothetical protein                              4.10                        \+ 1.7   \+ 1.9    \+ 4.7    \+ 2.7   \+ 2.1   1.7E-03
  337.m00049_x\_at   XM_644075           Hypothetical protein                              2.48                        \+ 2.9   \+ 5.2    \+ 4.5    \+ 1.7   \+ 1.0   1.5E-03
  EHI_148740_at      XM_001913345        Hypothetical protein                              8.19                        \+ 1.9   \+ 2.7    \+ 4.4    \+ 1.7   \+ 1.3   1.0E-06
  79.m00141_x\_at    XM_648476           Hypothetical protein                              2.90                        \+ 2.0   \+ 3.1    \+ 4.4    \+ 1.7   \+ 1.2   2.4E-02
  EHI_189190_x\_at   XM_644225           Hypothetical protein                              3.25                        \+ 1.7   \+ 4.8    \+ 4.4    \- 1.0   \- 1.9   4.3E-05
  EHI_039720_at      XM_642957           Hypothetical protein                              2.53                        \- 1.0   \+ 2.1    \+ 4.4    \+ 3.3   \+ 1.4   1.6E-05
  EHI_051040_s\_at   XM_647890           Hypothetical protein                              6.82                        \+ 1.5   \+ 2.7    \+ 4.4    \+ 2.5   \+ 2.8   1.9E-03
  EHI_139080_at      XM_643428           Longevity-assurance family protein                5.38                        \- 2.3   \+ 1.2    \+ 4.4    \+ 2.3   \+ 2.0   4.4E-06
  EHI_067230_x\_at   XM_647567           Hypothetical protein                              6.18                        \+ 9.7   \+ 13.6   \+ 4.2    \- 1.3   \- 1.1   1.4E-07
  EHI_055680_at      XM_646949           Heat shock protein, Hsp20 family, putative        5.63                        \+ 2.0   \+ 4.6    \+ 4.2    \+ 1.6   \+ 1.2   1.4E-03
  EHI_086500_s\_at   XM_646060           Short chain dehydrogenase                         4.86                        \+ 6.1   \+ 8.1    \+ 4.2    \+ 1.1   \- 1.4   1.2E-04
  EHI_148970_s\_at   XM_652477           Regulator of nonsense transcripts, putative       9.86                        \+ 5.9   \- 1.0    \- 4.1    \- 5.1   \- 9.7   1.5E-07
  EHI_139090_at      XM_643429           Hypothetical protein                              5.95                        \+ 1.6   \+ 1.9    \+ 4.1    \+ 1.3   \- 1.5   6.2E-05
  167.m00129_at      XM_646319           Hypothetical protein                              3.36                        \+ 2.4   \+ 4.8    \+ 4.0    \+ 2.0   \+ 1.9   1.6E-03
  EHI_110840_s\_at   XM_649191           Regulator of nonsense transcripts, putative       9.73                        \+ 6.5   \+ 1.0    \- 4.0    \- 4.6   \- 8.7   1.2E-07
  EHI_178130_at      XM_646412           Hypothetical protein                              5.09                        \+ 2.0   \+ 3.2    \+ 4.0    \+ 2.4   \+ 2.8   5.9E-05
  EHI_110370_at      XM_651955           Hypothetical protein                              4.52                        \- 1.3   \+ 1.3    \+ 3.9    \+ 2.6   \+ 4.1   2.0E-04
  EHI_070810_x\_at   XM_649317           Regulator of nonsense transcripts, putative       4.76                        \+ 7.4   \- 1.1    \- 3.9    \- 4.3   \- 4.8   1.6E-05
  EHI_004990_at      XM_647768           Ankyrin, putative                                 6.30                        \+ 2.0   \+ 4.3    \+ 3.8    \+ 2.4   \+ 3.0   5.1E-05
  EHI_023330_at      XM_650547           Hypothetical protein                              9.16                        \+ 6.5   \+ 1.4    \- 3.6    \- 7.1   \- 8.3   8.2E-07
  EHI_005160_s\_at   XM_647757           Hypothetical protein                              2.94                        \+ 2.9   \+ 4.5    \+ 3.4    \+ 1.6   \+ 1.2   6.7E-03
  EHI_028940_at      XM_647571           Hypothetical protein                              8.44                        \+ 6.1   \+ 6.5    \+ 3.4    \- 1.0   \- 1.2   1.4E-07
  EHI_033240_x\_at   XM_645809           Riboflavin kinase/FAD synthetase, putative        6.61                        \+ 1.4   \+ 4.6    \+ 3.4    \+ 3.0   \+ 2.6   8.6E-07
  493.m00030_x\_at   XM_643175           Hypothetical protein                              8.73                        \+ 3.9   \+ 5.2    \+ 3.3    \- 1.8   \- 1.9   1.4E-07
  15.m00356_at       XM_651173           Hypothetical protein                              7.03                        \+ 3.4   \+ 4.2    \+ 3.3    \+ 1.7   \+ 2.1   1.8E-03
  EHI_110480_at      XM_651901           Hypothetical protein                              4.51                        \+ 2.3   \+ 4.2    \+ 3.3    \+ 2.9   \+ 1.7   1.5E-04
  EHI_140620_x\_at   XM_645555           Hypothetical protein                              2.32                        \+ 2.1   \+ 5.9    \+ 3.2    \+ 1.3   \+ 1.2   2.3E-02
  EHI_136430_at      XM_650171           Hypothetical protein                              4.08                        \+ 7.5   \+ 7.8    \+ 3.2    \- 2.3   \+ 1.0   4.1E-06
  373.m00052_s\_at   XM_643804           Hypothetical protein                              6.53                        \+ 4.1   \+ 2.0    \+ 3.1    \+ 1.0   \- 1.1   7.9E-04
  EHI_141030_at      XM_649510           DNA methyltransferase, putative                   5.97                        \+ 2.4   \+ 1.7    \+ 2.3    \+ 3.9   \+ 4.1   3.6E-05
  EHI_178520_at      XM_647939           Regulator of nonsense transcripts, putative       6.30                        \+ 6.2   \- 1.4    \- 2.1    \- 1.9   \- 1.4   8.7E-06
  EHI_142270_at      XM_648119           Hypothetical protein                              8.27                        \+ 3.7   \+ 4.1    \+ 2.0    \- 1.0   \- 1.1   2.9E-04
  EHI_014340_at      XM_649988           Hypothetical protein                              6.45                        \+ 2.7   \+ 5.2    \+ 1.9    \+ 1.1   \- 1.1   4.9E-05
  EHI_064440_at      XM_648922           Hypothetical protein                              5.03                        \- 1.5   \- 1.2    \+ 1.7    \+ 2.5   \+ 4.0   2.0E-03
  EHI_120930_s\_at   XM_649257           Protein kinase domain containing protein          2.61                        \+ 6.8   \- 1.0    \+ 1.5    \+ 2.3   \+ 1.8   2.4E-03
  637.m00013_s\_at   XM_642916           Regulator of nonsense transcripts, putative       2.92                        \+ 6.6   \- 1.2    \- 1.5    \- 1.5   \- 1.1   3.6E-05
  EHI_031640_at      XM_648447           Hypothetical protein                              6.98                        \+ 2.3   \- 3.1    \+ 1.5    \+ 3.6   \+ 5.8   1.8E-06
  EHI_103640_at      XM_643960           Protein kinase domain containing protein          3.10                        \+ 5.2   \- 1.0    \- 1.4    \+ 1.4   \+ 1.2   5.6E-04
  EHI_014910_s\_at   XM_001914428        Hypothetical protein                              2.99                        \+ 6.0   \+ 1.5    \- 1.3    \+ 1.4   \- 1.2   2.7E-04
  EHI_038910_at      XM_651787           Hypothetical protein                              2.57                        \+ 5.3   \+ 2.3    \+ 1.2    \+ 1.6   \- 1.0   5.1E-03
  EHI_190460_at      XM_646352           Amino acid transporter, putative                  3.11                        \- 1.2   \- 1.4    \+ 1.2    \+ 2.2   \+ 3.9   2.9E-03
  EHI_084710_at      XM_650002           Hypothetical protein                              4.27                        \+ 5.3   \+ 2.3    \+ 1.1    \+ 2.2   \+ 1.2   5.1E-04
  EHI_054680_at      XM_646972           Hypothetical protein                              3.09                        \- 1.2   \- 1.4    \- 1.1    \+ 2.7   \+ 5.9   4.8E-04
  50.m00196_s\_at    XM_649450           Hypothetical protein                              4.95                        \+ 4.2   \- 1.5    \- 1.1    \+ 1.2   \- 1.4   9.0E-05
  EHI_046040_s\_at   XM_645992           Hypothetical protein                              5.08                        \+ 6.5   \+ 1.5    \- 1.1    \- 1.0   \- 1.6   1.1E-05

The probe set IDs, accession numbers, common names, basal expressions, fold changes, and p values of most highly induced genes upon L-cysteine deprivation are shown.

###### 

List of most highly down-regulated genes upon L-cysteine deprivation

  Probe set ID       Accession numbers   Common Names                                  Basal Expression (log~2~)   3h       6h     12h       24h       48h       p value
  ------------------ ------------------- --------------------------------------------- --------------------------- -------- ------ --------- --------- --------- ---------
  72.m00179_at       XM_648717           Hypothetical protein                          8.8                         \+ 1.1   +1.4   \- 2.8    \- 15.3   \- 22.8   2.5E-06
  EHI_045340_s\_at   XM_648481           NADPH-dependent oxidoreductase (EhNO2)        10.6                        \- 1.9   -1.9   \- 3.0    \- 10.6   \- 8.3    1.4E-07
  EHI_023330_at      XM_650547           Hypothetical protein                          9.2                         \+ 6.5   +1.4   \- 3.6    \- 7.1    \- 8.3    8.2E-07
  EHI_148970_s\_at   XM_652477           Regulator of nonsense transcripts, putative   9.9                         \+ 5.9   -1.0   \- 4.1    \- 5.1    \- 9.7    1.5E-07
  EHI_110840_s\_at   XM_649191           Regulator of nonsense transcripts, putative   9.7                         \+ 6.5   +1.0   \- 4.0    \- 4.6    \- 8.7    1.2E-07
  EHI_070810_x\_at   XM_649317           Regulator of nonsense transcripts, putative   4.8                         \+ 7.4   -1.1   \- 3.9    \- 4.3    \- 4.8    1.6E-05
  EHI_049960_at      XM_651359           Hypothetical protein                          7.8                         \+ 2.4   -1.6   \- 5.1    \- 3.3    \- 2.9    5.1E-07
  EHI_182260_s\_at   XM_001914319        Cysteine protease, putative                   7.8                         \- 1.7   -3.2   \- 2.5    \- 3.2    \- 6.3    2.7E-05
  EHI_052890_at      XM_645369           Hypothetical protein                          9.0                         \- 1.1   -6.3   \- 11.1   \- 3.0    \- 2.6    3.5E-05
  EHI_077280_s\_at   XM_649853           Leucine rich repeat protein, BspA family      8.4                         \- 5.4   -6.7   \- 2.2    \- 2.7    \- 1.1    2.5E-03
  EHI_178790_at      XM_651153           Hypothetical protein                          4.7                         \- 1.7   -5.1   \- 1.6    \+ 2.5    \+ 3.0    1.2E-04
  EHI_094060_s\_at   XM_001913553        Actin binding protein, putative               9.2                         \+ 1.3   -3.5   \- 5.0    \- 2.5    \- 3.2    1.8E-03
  371.m00031_s\_at   XM_643815           Leucine rich repeat protein                   8.3                         \- 4.3   -3.2   \- 2.4    \- 2.4    \- 1.4    1.5E-02
  EHI_049570_at      XM_650791           RhoGAP domain containing protein              6.9                         \+ 2.1   -2.3   \- 5.0    \- 2.3    \- 2.6    8.7E-04
  EHI_130710_at      XM_644068           Myb-like DNA-binding protein                  6.3                         \+ 1.3   -1.9   \- 4.4    \- 2.2    \- 1.9    1.6E-05
  EHI_197440_at      XM_646593           Hypothetical protein                          10.6                        \+ 1.5   -2.7   \- 4.1    \- 1.9    \- 2.6    1.0E-03
  330.m00075_x\_at   XM_644126           Hypothetical protein                          6.9                         \+ 1.1   +1.0   \- 3.3    \+ 1.8    \- 7.2    1.9E-03
  EHI_148650_at      XM_652381           Leucine rich repeat/phosphatase domain        7.2                         \- 2.4   -4.5   \- 2.9    \- 1.7    \- 1.6    1.2E-03
                                         containing protein                                                                                                      
  EHI_050660_at      XM_651502           Hypothetical protein                          7.3                         \+ 1.7   -3.7   \- 4.4    \- 1.7    \- 1.6    8.1E-04
  EHI_044890_at      XM_652115           Helicase, putative                            5.6                         \- 1.0   -4.3   \- 2.3    \- 1.6    \- 1.4    6.5E-03
  49.m00187_x\_at    XM_649517           Fatty acid elongase, putative                 4.8                         \+ 1.3   -5.6   \- 5.4    \- 1.6    \- 1.7    3.3E-05
  EHI_094780_s\_at   XM_001914195        Pescadillo homolog, putative                  5.7                         \+ 1.4   -2.9   \- 4.0    \- 1.6    \- 2.1    8.5E-03
  260.m00059_s\_at   XM_644821           Phospholipase D like protein                  4.4                         \+ 1.7   -3.6   \- 4.2    \- 1.6    \- 3.0    2.1E-03
  EHI_140530_at      XM_649099           Hypothetical protein                          4.9                         \+ 1.4   -2.3   \- 4.5    \+ 1.6    \+ 1.3    1.1E-04
  EHI_145850_at      XM_650629           Hypothetical protein                          4.9                         \+ 1.1   -3.2   \- 5.8    \- 1.5    \- 2.0    2.3E-03
  EHI_046630_at      XM_645444           Rho family GTPase                             6.0                         \- 1.1   -4.4   \- 4.4    \+ 1.5    \- 1.2    2.2E-04
  EHI_187100_at      XM_651384           Hypothetical protein                          6.9                         \- 1.3   -4.4   \- 2.4    \- 1.5    \- 1.1    2.5E-06
  849.m00008_s\_at   XM_642804           Leucine rich repeat protein                   7.9                         \- 5.1   -3.5   \- 2.1    \- 1.5    \- 1.1    1.4E-02
  EHI_009840_s\_at   XM_652013           Hypothetical protein                          11.1                        \- 4.3   -1.2   \+ 1.4    \+ 1.5    \+ 1.6    4.0E-07
  EHI_039330_at      XM_648669           Hypothetical protein                          9.3                         \+ 1.1   -4.3   \- 2.9    \- 1.5    \- 1.4    2.6E-02
  266.m00066_s\_at   XM_644755           Hypothetical protein                          7.1                         \+ 1.6   +1.0   \- 1.3    \+ 1.4    \- 6.6    1.3E-05
  EHI_029500_s\_at   XM_644980           Hypothetical protein                          6.9                         \+ 1.7   -1.0   \- 1.4    \+ 1.4    \- 7.4    1.6E-04
  216.m00082_x\_at   XM_645403           Hypothetical protein                          6.0                         \- 2.3   -4.1   \- 3.9    \- 1.4    \- 1.8    4.4E-04
  EHI_196770_s\_at   XM_001914173        Leucine rich repeat protein                   8.2                         \- 3.4   -4.6   \- 2.1    \- 1.3    \+ 1.0    2.9E-02
  EHI_034590_s\_at   XM_001914026        Hypothetical protein                          7.1                         \+ 1.2   -1.2   \- 1.4    \+ 1.3    \- 6.4    5.2E-05
  EHI_107660_at      XM_644692           Hypothetical conserved, protein               9.1                         \- 5.7   -2.0   \+ 1.1    \+ 1.3    \+ 1.7    1.1E-06
  207.m00059_x\_at   XM_645533           Actinin-like protein, putative                5.4                         \+ 1.7   -5.4   \- 2.4    \- 1.3    \- 1.6    6.4E-03
  EHI_182540_at      XM_651612           Hypothetical protein                          6.3                         \+ 1.0   -3.2   \- 4.1    \+ 1.3    \- 1.0    5.4E-04
  EHI_010130_at      XM_651999           Hypothetical protein                          6.6                         \- 9.5   -5.3   \- 1.3    \- 1.3    \- 1.1    4.0E-06
  EHI_018030_s\_at   XM_001914259        Hypothetical protein                          7.1                         \+ 1.4   +1.0   \- 1.1    \+ 1.3    \- 11.0   4.3E-05
  EHI_020830_s\_at   XM_001913952        Hypothetical protein                          9.4                         \+ 1.4   -1.3   \- 1.2    \+ 1.3    \- 9.9    1.4E-05
  EHI_002240_s\_at   XM_645752           Hypothetical protein                          7.1                         \+ 1.4   -1.0   \- 1.2    \+ 1.2    \- 6.6    1.9E-04
  EHI_196760_s\_at   XM_643708           Hypothetical protein                          9.4                         \+ 1.5   -1.3   \- 1.2    \+ 1.2    \- 8.4    1.0E-05
  EHI_037700_s\_at   XM_643865           Hypothetical protein                          7.1                         \+ 1.4   -1.1   \- 1.3    \+ 1.2    \- 7.0    3.3E-05
  EHI_189540_x\_at   XM_645163           Hypothetical protein                          5.0                         \+ 1.5   -4.1   \- 2.4    \- 1.2    \- 2.1    9.9E-03
  EHI_196720_s\_at   XM_643106           Hypothetical protein                          7.1                         \+ 1.5   -1.1   \- 1.3    \+ 1.2    \- 10.1   2.8E-04
  375.m00058_s\_at   XM_643788           Hypothetical protein                          7.1                         \+ 1.5   -1.1   \- 1.3    \+ 1.2    \- 6.3    2.6E-04
  194.m00101_s\_at   XM_645779           Hypothetical protein                          7.2                         \+ 1.4   -1.1   \- 1.4    \+ 1.2    \- 6.9    8.0E-05
  372.m00048_s\_at   XM_643812           Protein kinase domain containing protein      6.0                         \+ 1.1   -4.0   \- 4.0    \+ 1.1    \- 1.1    1.8E-04
  EHI_144150_s\_at   XM_001914451        Hypothetical protein                          6.3                         \+ 1.8   -1.6   \- 2.0    \+ 1.1    \- 13.2   1.5E-04
  EHI_020840_s\_at   XM_001913953        Hypothetical protein                          7.4                         \+ 1.7   -1.4   \- 1.9    \- 1.1    \- 18.9   4.1E-05
  EHI_103840_at      XM_648260           DNA repair protein, putative                  6.1                         \+ 1.2   -3.1   \- 4.3    \+ 1.0    \- 1.1    3.1E-03
  506.m00025_s\_at   XM_643137           Hypothetical protein                          8.3                         \+ 1.1   -1.0   \- 1.9    \- 1.0    \- 6.8    9.9E-04
  390.m00061_s\_at   XM_643707           Hypothetical protein                          7.4                         \+ 1.7   -1.5   \- 1.7    \- 1.0    \- 12.6   1.1E-05
  EHI_145330_s\_at   XM_001913871        Hypothetical protein                          6.5                         \+ 1.2   -1.1   \- 1.8    \- 1.0    \- 6.5    5.1E-05
  EHI_099250_at      XM_649200           Hypothetical protein                          6.3                         \+ 1.2   -1.9   \- 4.0    \- 1.0    \- 1.3    2.1E-04
  EHI_196770_s\_at   XM_001914173        Hypothetical protein                          7.4                         \+ 1.8   -1.4   \- 1.5    \- 1.0    \- 17.1   2.7E-05
  190.m00086_s\_at   XM_645857           Hypothetical protein                          8.4                         \+ 1.0   -1.1   \- 2.0    \- 1.0    -6.4      1.1E-03

The probe set IDs, accession numbers, common names, basal expressions, fold changes, and p values of most highly down-regulated genes upon L-cysteine deprivation are shown.

![**Functional distribution of differentially expressed genes upon L-cysteine deprivation**. Genes were grouped according to putative functions inferred from the respective annotations. The exact number of changed transcripts is shown beside each column.](1471-2164-12-275-1){#F1}

To verify the data obtained by Affymetrix-based microarray, we performed quantitative RT-PCR on five genes: two each from significantly up- (EHI_173950 and EHI_138480) and down-regulated genes (EHI_045340 and EHI_052890), respectively, and one invariant gene (EHI_056690), based on Affymetrix analysis. The results of qRT-PCR agreed well with the microarray data for all five transcripts tested (Table [3](#T3){ref-type="table"}). The modulated genes were grouped into broad categories, based on the protein BLAST at NCBI and InterProScan at EMBL, and discussed below (Figure [1](#F1){ref-type="fig"}).

###### 

Verification of the microarray data by qRT-PCR

  Common Name                                        Accession Number   Fold Change                                
  -------------------------------------------------- ------------------ ------------- -------- --------- --------- --------
  Major fascilitator superfamily (MFS) transporter   XM_647419          2.0           12.8     7.2       4.2       2.3
                                                                                                                   
                                                                        (4.1)         (14.6)   (9.9)     (4.7)     (2.6)
                                                                                                                   
  Iron sulfur flavoprotein (ISF)                     XM_650038          1.8           4.4      14.9      5.5       2.8
                                                                                                                   
                                                                        (3.6)         (6.8)    (9.8)     (5.4)     (4.2)
                                                                                                                   
  NADPH-dependent oxidoreductase (EhNO2)             XM_648481          -3.0          -3.0     -6.0      -8.4      -7.8
                                                                                                                   
                                                                        (-1.9)        (-1.9)   (-3.0)    (-10.6)   (-8.3)
                                                                                                                   
  Hypothetical protein                               XM_645369          -2.2          -6.4     -12.9     -3.4      -2.7
                                                                                                                   
                                                                        (-1.1)        (-6.3)   (-11.1)   (-3.0)    (-2.6)
                                                                                                                   
  RNA polymerase II 15-kDa subunit                   XM_643999          1.0           -1.2     1.1       -1.3      -1.3
                                                                                                                   
                                                                        (1.4)         (1.2)    (1.2)     (1.1)     (1.2)

The common names, accession numbers, and fold changes of the selected genes upon L-cysteine deprivation are shown. The upper values are the fold changes in the expression obtained from qRT-PCR. The corresponding fold changes in the expression values obtained from Affymetrix analysis are shown in brackets.

Effect of L-cysteine deprivation on SAA metabolism
--------------------------------------------------

To further explore the role of L-cysteine in the regulation of expression of genes involved in SAA metabolism and associated pathways, we investigated their expression upon L-cysteine deprivation. As shown in Figure [2A](#F2){ref-type="fig"}, most of the genes involved in SAA metabolism except phosphoserine aminotransferase (PSAT) were not modulated by \>3 fold upon L-cysteine deprivation. PSAT, an enzyme that catalyzes the reversible conversion of 3-phosphohydroxypyruvate to L-phosphoserine, the second step of phosphorylated L-serine biosynthetic pathway, was down-regulated by 3.3 fold at 48 h (Figure [2B](#F2){ref-type="fig"}). Other genes that were slightly modulated by L-cysteine deprivation included methionine adenosyltransferase (MAT) and phosphoglycerate dehydrogenase (PGDH), which were induced by \>2 fold at early (3-6 h) and late (24-48 h) time points of L-cysteine deprivation, respectively (Figure [2B](#F2){ref-type="fig"}). This lack of changes in the expression of genes involved in SAA metabolism might be due to their high basal expression (except CS3 and SAT2, which have relatively low expression) under normal conditions(Additional file [4](#S4){ref-type="supplementary-material"}). Alternatively, it may be because L-cysteine has a very limited influence on the expression of the genes involved in SAA metabolism in *E. histolytica*. However, L-cysteine has been shown to significantly modulate the metabolic flux across SAA metabolism in *E. histolytica*\[[@B12]\]. In contrast to *E. histolytica*, L-cysteine availability is known to have a significant influence on the expression of the genes involved in SAA metabolism in other eukaryotic cells \[[@B18]\]. For example, in HepG2/C3A cells, L-cysteine deprivation resulted in the induction of cysteinyl-tRNA synthetase, glutamate-cysteine ligase, L-cystine-glutamate transporter, cystathionine γ-lyase, and glutamate-cysteine ligase, and a down-regulation of 3-phosphoadenosine 5-phosphosulfate synthase and sulfite oxidase \[[@B18]\].

![**Effect of L-cysteine deprivation on expression of the genes involved in sulfur-containing amino acid metabolism**. ***A***) General scheme of sulfur-containing amino acid metabolism in *E. histolytica*. Abbreviations: CS, cysteine synthase; SAT, serine O-acetyltransferase; PGDH, phosphoglycerate dehydrogenase; MGL, methionine γ-lyase; MAT, methionine adenosyl-transferase; MT, methyl-transferase; SAHH, S-adenosylhomocysteine hydrolase; NifS, cysteine desulfurase; PSAT, phosphoserine aminotransferase; PSP, phosphoserine phosphatase; OAS; O-acetylserine; SMC, S-methylcysteine; SAH, S-adenosylhomocysteine; SAM, S-adenosyltransferase; P-Ser, O-phosphoserine; 3-PGA, 3-phosphoglycerate. ***B***) Modulation of transcripts encoding enzymes involved in sulfur containing amino acid metabolism. Gene IDs: CS1, EHI_171750; CS2, EHI_160930; CS3, EHI_060340; MAT, 70.m00173; MGL1, EHI_144610; MGL2, EHI_142250; NifS; EHI_136380; PGDH, EHI_060860; PSAT, EHI_026360; SAHH, EHI_068250; SAT2, EHI_021570; SAT3, EHI_153430.](1471-2164-12-275-2){#F2}

We have recently shown by metabolomic analysis that the synthesis of OAS and SMC markedly increased upon L-cysteine deprivation in *E. histolytica*. OAS in bacteria is known to regulate the genes of cysteine regulon, and increment in its level modulates the expression of the genes involved in L-cysteine and sulfide synthesis \[[@B19]\]. However, no such regulation of genes of cysteine biosynthetic pathway was observed in *E. histolytica*, except a 2 fold down-regulation of a gene encoding SAT2, and slight induction of a gene encoding SAT3 (Figure [2B](#F2){ref-type="fig"}). These results imply that L-cysteine does not significantly modulate expression of the genes involved in SAA metabolism in *E. histolytica*; however, it affects the flux of SAA metabolism by post-transcriptional or post-translational mechanisms.

Effect of L-cysteine deprivation on the genes involved in oxidative and nitrosative stress defense
--------------------------------------------------------------------------------------------------

The *E. histolytica*genome contains several genes encoding ROS and RNS detoxifying proteins, such as peroxiredoxin, rubrerythrin, hybrid-cluster protein, superoxide dismutase (SOD), and flavodiiron proteins (FDPs) \[[@B6]\]. FDPs are widespread in prokaryotes, and known to be involved in the reduction of oxygen and/or nitric oxide whereas peroxiredoxin, rubrerythrin, hybrid-cluster protein, and superoxide dismutase (SOD) are involved in the detoxification of H~2~O~2~and/or superoxide radicals \[[@B20]-[@B22]\]. Although L-cysteine deprivation led to the increment in the level of intracellular ROS \[[@B12]\], the genes encoding putative ROS-and RNS-detoxifying proteins in *E. histolytica*were not significantly modulated (Figure [3A](#F3){ref-type="fig"}). This is consistent with the previous studies that genes encoding known ROS and RNS detoxification pathways are not modulated in response to H~2~O~2~-mediated oxidative or DPTA-NONOate-mediated nitrosative stress in *E. histolytica*\[[@B23]\]. The lack of induction of the genes involved in oxidative/nitrosative stress is likely due to their high baseline expression even in the absence of oxidative or nitrosative stress. While most of the known genes in the ROS and RNS detoxification pathways were not modulated, one (EHI_129890) of the four FDP genes was slightly (up to 2.6 fold) up-regulated upon L-cysteine deprivation (Figure [3A](#F3){ref-type="fig"}). These findings suggest that *E. histolytica*might employ other post-transcriptional or post-translational regulatory mechanisms, such as RNA transport, protein modifications, allosteric regulations, and redirection of metabolic fluxes, to cope up with the oxidative stress.

![**Comparison of the *E. histolytica*genes modulated upon L-cysteine deprivation and oxidative or nitrosative stress**. ***A***) Expression kinetics upon L-cysteine deprivation of the genes previously inferred for oxidative and/or nitrosative stress defense. Gene/protein ID of enzymes are: type A flavoproteins (Flavodiiron proteins), EHI_159860, EHI_064530, EHI_096710, and EHI_129890; peroxiredoxin, EHI_145840; iron containing SOD, EHI_159160; rubrerythrin, EHI_134810; hybrid cluster protein, EHI_004600. ***B**)*A Venn diagram showing the number of overlapping genes modulated upon L-cysteine deprivation and oxidative (1 mM of H~2~O~2~for 1 h), or nitrosative stress (200 μM of DPTA-NONOate for 1 h), as described \[[@B23]\].](1471-2164-12-275-3){#F3}

The comparison of the genes modulated in response to L-cysteine deprivation with those modulated upon oxidative or nitrosative stress showed a very limited overlap (Figure [3B](#F3){ref-type="fig"}). Genes modulated upon L-cysteine deprivation shared only 27 or 31 genes with those modulated by oxidative or nitrosative stress, respectively (Figure [3B](#F3){ref-type="fig"}). Of these shared genes, 17 genes were shared by all the three conditions, suggesting that these genes play a general (or central) role in the response against L-cysteine deprivation and oxidative/nitrosative stress. A list of these shared genes is shown in Additional file [5](#S5){ref-type="supplementary-material"}. Among the genes that were up-regulated by L-cysteine deprivation and oxidative/nitrosative stress were several genes encoding iron sulfur flavoproteins (ISF) (EHI_067720, EHI_025710, EHI_138480). Interestingly, ISFs were among the most highly up-regulated genes by L-cysteine deprivation. ISFs constitute a wide-spread family of redox-active proteins found predominantly in anaerobic prokaryotes \[[@B24]\]. They are flavin mononucleotide (FMN) cofactor, and iron-sulfur \[Fe-S\] clusters containing proteins with an unusually compact cysteine motif \[[@B25]\]. The deduced amino acid sequences of amebic ISFs also suggest the presence of this compact cysteine motif (CX2CX2CX5-7C) that is most likely involved in the ligation of \[4Fe-4S\] clusters \[[@B25],[@B26]\].

Iron sulfur flavoproteins belong to a novel family of proteins that are widely distributed in distantly related anaerobic prokaryotes. Interestingly, *E. histolytica*and *Trichomonas vaginalis*are the only members of the domain *Eukarya*that possess ISFs \[6, 26\]. There are at least 7 independent genes for ISFs in the genome of *E. histolytica*. However, the total number entries in *E. histolytica*database representing ISF genes is 13 as some of the sequences show very high mutual sequence identities (95-99%). A total of 7 probe sets representing 5 different ISF genes were up regulated ≥3 fold at one or more time points upon L-cysteine deprivation (Figure [4](#F4){ref-type="fig"}). Two of these ISF genes (EHI_138480 and EHI_025710) showed a maximum induction of 9.8 and 8.7 fold at 12 h of L-cysteine deprivation, respectively. The remaining probe sets were induced by only 3-6 folds upon L-cysteine deprivation. Three ISF genes, including two ISF genes highly induced upon L-cysteine deprivation (EHI_138480 and EHI_025710), were also induced by oxidative stress \[[@B23]\]. In contrast to their induction in response to L-cysteine deprivation or oxidative stress, two ISF genes (EHI_067720, EHI_134740) were down-regulated by 2-5 folds on day 1 and day 29 in the mouse model of intestinal amoebiasis \[[@B27]\]. These findings suggest that the expression of ISFs is regulated by the availability of the reactive oxygen species, and agree with the proposed function of ISFs in anaerobes in combating oxidative stress by reducing O~2~and H~2~O~2~to water \[[@B28]\]. In addition to oxidative stress, ISFs and ISF-related proteins were also induced upon the deprivation of sulfate or L-cysteine in bacteria \[[@B29]\].

![**Induction of iron sulfur flavoproteins upon L-cysteine deprivation in *E. histolytica***. Values are expressed as fold changes of the transcripts under L-cysteine-deprived conditions, relative to the trophozoites cultured in medium containing normal concentration of L-cysteine.](1471-2164-12-275-4){#F4}

Effect of L-Cysteine deprivation on membrane transport
------------------------------------------------------

Adaptive response to altered environmental conditions may include a significant alteration in the gene expression of the membrane transporters that are involved in the intake or efflux of various metabolites. A total of 4 genes with putative transport functions were significantly modulated in response to the removal of L-cysteine from the culture medium (Figure [5A](#F5){ref-type="fig"}). Two genes (EHI_173950 and EHI_186810) encoding major facilitator super-family (MFS) transporters showed maximum induction of 14.6 (EHI_173950) and 3.5 fold (EHI_186810) at 6 h upon L-cysteine deprivation. The third gene (EHI_190460) that encodes for an amino acid transporter was also induced by 3.9 fold at 48 h, whereas the fourth gene (EHI_152720) that encodes a small conductance mechanosensitive ion channel was down-regulated by 3.7 at 12 h upon L-cysteine deprivation (Additional files [2](#S2){ref-type="supplementary-material"} and [3](#S3){ref-type="supplementary-material"}). The increments (\~2 fold) in L-serine and L-threonine levels upon L-cysteine deprivation \[[@B12]\] may be attributed to either increased expression of amino acid transporter or MFS transporter, or reversal of L-cysteine-mediated inhibition of their transporters.

![**Changes in the expression of the genes encoding membrane transporters and regulator of nonsense transcripts upon L-cysteine deprivation**. Values are expressed as fold changes in the expression of the transcripts relative to the trophozoites culture in the presence of normal concentration of L-cysteine. ***A***) Changes in the expression of the genes encoding putative transporter proteins. ***B***) Time-dependent changes in the expression of the genes encoding putative regulators of nonsense transcripts.](1471-2164-12-275-5){#F5}

MFS is a large superfamily of membrane transporters present ubiquitously in bacteria, archaea, and eukarya \[[@B30]\]. They are involved in the symport, antiport, or uniport of various substrates including sugars, phosphorylated glycolytic intermediates, amino acids, polyols, drugs, neurotransmitters, and osmolites \[[@B30]\]. MFS transporters from yeast and bacteria are known to be involved in the transport of the metabolites of L-cysteine biosynthetic pathway including L-cysteine and O-acetylserine \[[@B31],[@B32]\]. L-Cysteine deprivation resulted in drastic increments in various metabolites such as SMC, OAS, glycerol 3-phosphate and isopropanolamine, and sharp decrements in L-cysteine and L-cystine \[[@B12]\]. Thus, it may be possible that these MFS transporters are involved in either intake or efflux of the metabolites modulated upon L-cysteine deprivation. As the contribution of L-cysteine biosynthetic pathway to L-cysteine synthesis is negligible, both L-cysteine and L-cystine are completely deprived upon L-cysteine deprivation. Under this condition, *E. histolytica*trophozoites may induce expression of certain high affinity L-cysteine or L-cystine transporters. The genome of *E. histolytica*contains about 24 different genes for MFS transporters \[[@B6]\]. However, exact substrate specificities, and physiological roles of these MFS transporters in *E. histolytica*remain to be established.

Effect of L-cysteine deprivation on general metabolism
------------------------------------------------------

Recently, we demonstrated that in addition to the drastic metabolic changes in SAA metabolism, L-cysteine also regulates other metabolic pathways including phospholipid and energy metabolism \[[@B12]\]. However, like SAA metabolism, most of the genes involved in phospholipid or energy metabolism showed only minor changes in their expressions in response to L-cysteine deprivation. However, some transcriptional changes in the expression of genes involved in energy metabolism were noted. Genes encoding hexokinase, phosphoglycerate mutase, and malate dehydrogenase were slightly down regulated (Additional file [1](#S1){ref-type="supplementary-material"}). Down-regulation of these genes may partially contribute to the overall decrease in the metabolic flux across glycolysis as reported in our previous metabolomic study of L-cysteine deprivation \[[@B12]\].

Transcripts that showed significant induction upon L-cysteine deprivation include a gene encoding putative glucosamine 6-phosphate N-acetyltransferase (EHI_080280), which is known to be involved in chitin biosynthetic pathway (Table [1](#T1){ref-type="table"}). Two other genes encoding putative acetyltransferases (103.m00159, EHI_096770) were also induced 3-5 fold upon L-cysteine deprivation (Table [1](#T1){ref-type="table"}; Additional file [2](#S2){ref-type="supplementary-material"}). These acetyltransferases contain maltose/galactose-O-acetyltransferase domains, and are known to be involved in the acetylation of a variety of substrates such as maltose, galactose, glucosamine, glucose, and fructose. However, the exact substrate specificity, physiological relevance, and the pathways that these acetyltransferases are involved in, are not known in *E. histolytica*. EHI_096770 was also induced upon H~2~O~2~-mediated oxidative (4 fold) or DPTA-NONOate-mediated nitrosative stress (2.7 fold) in *E. histolytica*\[[@B23]\]. A gene encoding cyst wall specific glycoprotein Jacob was induced during the early time points (Additional file [2](#S2){ref-type="supplementary-material"}). Both glucosamine 6-phosphate N-acetyltransferase and glycoprotein Jacob are involved in the encystation to form a chitin cell wall. However, it is not clear why the enzymes of chitin biosynthetic pathway are induced upon L-cysteine deprivation. Because some of the components of chitin biosynthetic pathway are known to be induced by oxidative stress \[[@B33]\], it is possible that stress induced by L-cysteine deprivation is also responsible for their induction.

A gene encoding riboflavin kinase/FAD synthetase that is involved in the synthesis of FAD or FMN cofactors was also induced up to 4.6 fold as an early response to L-cysteine deprivation (Table [1](#T1){ref-type="table"}). This may imply that there is an increase demand of FMN or FAD cofactors during L-cysteine deprivation. A gene (EHI_086500) encoding short chain dehydrogenase/reductases (SDR) was also induced up to 8 fold during early time points. SDR are NAD^+^/NADP^+^-dependent oxido-reductases, and are similar to alcohol dehydrogenases (Table [1](#T1){ref-type="table"}). Recently, we demonstrated that L-cysteine deprivation led to the accumulation of isopropanolamine, and *E. histolytica*possesses a pathway for its synthesis from methylglyoxal via aminoacetone \[[@B12]\]. SDR may be involved in the synthesis of isopropanolamine. Further biochemical analysis is required to better understand the significance of this L-cysteine-regulated dehydrogenase in *E. histolytica*.

In addition to the inductions of the genes discussed above, down-regulation of several genes encoding metabolic enzymes was also observed upon L-cysteine deprivation (Table [2](#T2){ref-type="table"}; Additional file [3](#S3){ref-type="supplementary-material"}). L-Cysteine deprivation resulted in down-regulation of the expression of a gene encoding a novel NADPH-dependent oxido-reductase (EHI_045340). *E. histolytica*possesses two isotypes of these oxido-reductases (EhNO1 and 2) which contain FAD- and 2\[4Fe-4S\]-binding domains \[[@B34]\]. However, the expression of only EhNO2 *(*EHI_045340), but not of EhNO1, was dramatically down-regulated in a time-dependent manner upon deprivation of L-cysteine. This gene was also induced by 7 fold upon the supplementation of 10 mM of L-cysteine in to the culture medium for 48 h \[[@B34]\]. In contrast, the level of EhNO1 remained unchanged in either presence or absence of L-cysteine \[[@B34]\]. Our recent biochemical analysis showed that EhNO1 and 2 catalyse the NADPH-dependent reduction of oxygen to hydrogen peroxide, and L-cystine to L-cysteine, and also function as ferric and ferredoxin-NADP^+^reductases. EhNO2 possesses 4-fold higher L-cystine reduction efficiency than EhNO1, where as EhNO1 is more efficient in reducing ferredoxin and ferric ion \[[@B34]\].

L-Cysteine deprivation also led to the down regulation of two genes encoding dUTP nucleotidohydrolase, which convert dUTP to dUMP, and thus are involved in removing dUTP from the deoxynucleotide pool, reducing the probability of this nucleotide being mistakenly incorporated into DNA. Genes encoding aspartate aminotransferase and aspartate ammonia lyase which are involved in the catabolism of Glu, Asp, and Asn were down-regulated on L-cysteine deprivation (Additional file [3](#S3){ref-type="supplementary-material"}). These amino acids can be catabolised to pyruvate through malate and fumarate \[[@B35]\]. As a result of decreased utilization of pyruvate upon L-cysteine deprivation, malate and fumarate are accumulated. Down-regulation of aspartate aminotransferase, and aspartate ammonia lyase will, in theory, lead to the decreased catabolism of these amino acids, and will prevent further accumulation of malate and fumarate. Aspartate aminotransferase in various organisms is known possess L-cysteine aminotransferase activity, which leads to the formation of mercaptopyruvate from L-cysteine \[[@B36]\]. Like EhNO2, this enzyme might also be regulated by the availability of its alternative substrate (L-cysteine), which is highly decreased upon L-cysteine deprivation. We also noticed time-dependent modulation in the expression of genes encoding putative fatty acid elongases. It has been shown that L-cysteine depletion decreases PtdEtn, and thus affects PtdCho/PtdEtn ratio, which potentially alters membrane fluidity, integrity, protein translocation across membranes, and membrane fusion events \[[@B12],[@B37]-[@B39]\]. Changes in the expression of fatty acid elongases may be associated with the modulation of fatty acid chains in the phospholipids to compensate for the physical changes induced by the decrement in PtdEtn upon L-cysteine deprivation.

Effect of L-cysteine deprivation on nucleic acid metabolism
-----------------------------------------------------------

Expression of several genes encoding proteins with functions in DNA/RNA metabolism was significantly modulated upon L-cysteine deprivation. They include several genes encoding regulator of nonsense transcripts (RENT), which participate in the nonsense mediated decay (NMD) of mRNAs containing a frameshift or a nonsense mutation (Figure [5B](#F5){ref-type="fig"}). This surveillance system protects cells from the production of non-functional proteins by eliminating mutant mRNAs. In addition to RNA surveillance, NMD is also involved regulating the abundance of hundreds of naturally occurring mRNAs \[[@B40]\].

The *E. histolytica*genome database at AmoebaDB \[[@B6],[@B41]\] contains 8 different entries that showed similarity to the RENTs from other higher eukaryotes. Based on the fact that some of these entries showed very high mutual sequence identities (85-95%), there are only 4 independent RENT genes in *E. histolytica*. All of the probe sets representing amebic RENTs showed a common pattern of expression during L-cysteine deprivation. They were induced during early time points of L-cysteine deprivation, and then down-regulated during the later time points (Figure [5B](#F5){ref-type="fig"}). Thus, like *Giardia lamblia*, the components of NMD pathway seem to be present and functional in *E. histolytica*. In *G. lamblia*, a large number of naturally occurring transcripts have been shown to be under the control of NMD \[[@B42]\]. However, the functionality, its targets, and role of NMD in the gene regulation of *E. histolytica*have not yet been demonstrated. Changes in the expression of RENTs suggest that some of the observed changes in the gene expression upon L-cysteine deprivation might be resulted from the corresponding changes in the NMD pathway of mRNA degradation.

Beside RENTs, several other genes with functions in nucleic acid metabolism were also modulated upon L-cysteine deprivation (Additional files [2](#S2){ref-type="supplementary-material"} and [3](#S3){ref-type="supplementary-material"}). A gene encoding a putative zinc finger protein was induced at the early time points, and then repressed at the later time points. Other genes, such as DNA/RNA helicase, a myb-like transcription factor, and a putative DNA repair protein were down-regulated upon L-cysteine deprivation. In addition, two genes encoding putative high mobility group (HMG) box proteins were slightly down-regulated upon L-cysteine deprivation. These proteins are associated with chromatin, and are involved in various processes including transcription, replication, recombination, and DNA repair \[[@B43]\]. Recently, expression of a large number of genes has been demonstrated to be modulated by the over-expression of a HMGB1 protein in *E*. *histolytica*\[[@B44]\]. Other genes encoding a putative La ribonucleoprotein and a ribosomal protein S30 were also up-regulated on L-cysteine deprivation. These results showed that L-cysteine modulates several genes involved in transcriptional and posttranscriptional regulation of the gene expression.

Effect of L-cysteine deprivation on signal transduction
-------------------------------------------------------

A significant number of genes (27) encoding signalling proteins were modulated in response to L-cysteine deprivation. Of these modulated genes, 11 were up-regulated and 16 were down-regulated (Figure [1](#F1){ref-type="fig"}). They include several genes encoding key signalling proteins such as protein kinases, phosphatases, guanine nucleotide exchange factors (Ras-GEF), GTPases, and GTPase activating proteins (GAPs). Alterations in mRNA abundance of these key signalling genes upon L-cysteine deprivation suggest a significant cellular re-programming to cope up with the consequences of L-cysteine deprivation or to help trophozoites get adapted to low cysteine environment. Deprivation of amino acids, including L-cysteine, is known to activates an amino acid response (AAR) that alters cellular functions by regulating the expression of various genes using transcriptional and post-transcriptional mechanisms \[[@B18],[@B45]\]. Activation of AAR leads to increased protein abundance of activating transcription factors, which in turn modulate the expression of genes containing AAR element (AARE) \[[@B18],[@B45]\]. However, such an AAR was not induced in *E. histolytica*, as it appears to lack activating transcription factors. These results suggest that *E. histolytica*does not employ canonical pathways to cope with the amino acid deprivation, but may employ other novel strategies.

Effect of L-cysteine deprivation on vesicular trafficking, cytoskeleton, and secretion
--------------------------------------------------------------------------------------

Response to changing environmental conditions by eukaryotic cells also includes modulation of protein degradation, targeting, transport to specific organelles, and secretion. Amino acid deprivation has been shown to regulate vesicular trafficking, secretion, exocytosis, and autophagy \[[@B46]\]. L-Cysteine limitation also modulates several proteins associated with these processes in *E. histolytica*. For example, four genes encoding putative cysteine proteases (EHI_123950, EHI_121160, EHI_160330, EHI_182260) were down-regulated in a time-dependent manner during L-cysteine deprivation (Table [2](#T2){ref-type="table"}; Additional file [3](#S3){ref-type="supplementary-material"}). A gene encoding vacuolar protein sorting 26 (Vps26) was up-regulated during L-cysteine deprivation. In addition, several genes encoding guanine nucleotide exchange factors (Ras-GEF), GTPases, and GTPase activating proteins (GAPs) were also modulated in response to L-cysteine deprivation. Modulation of the genes encoding putative ankyrin and actin binding protein suggested that L-cysteine deprivation may affect cytoskeleton re-organization, mobility and vesicular trafficking.

Miscellaneous
-------------

In addition to the modulation of above mentioned genes expression of several other transcripts was also changed upon L-cysteine deprivation. For example, a transcript for a putative heat shock protein 20 was induced 4-5 fold, and two WD40 domain-containing proteins were down-regulated 3-4 fold upon L-cysteine deprivation (Additional files [2](#S2){ref-type="supplementary-material"} and [3](#S3){ref-type="supplementary-material"}). WD-repeat proteins are a large family found in almost all eukaryotes and implicated in a variety of cellular functions ranging from signal transduction and transcription regulation to cell cycle control. One of the common functions of most of the WD-repeat proteins is to coordinate multi-protein complex assemblies \[[@B47]\]. Several genes encoding leucine-rich repeat proteins were down-regulated 3-6 fold at early time points upon L-cysteine deprivation (Additional file [3](#S3){ref-type="supplementary-material"}). Leucine-rich repeats serve as recognition motifs for surface proteins in bacteria and eukaryotes.

Repression of genes encoding ISF causes growth defects
------------------------------------------------------

In order to further characterize the functional role of the genes induced upon L-cysteine deprivation, we utilized the epigenetic silencing in *E. histolytica*G3 strain to repress genes of interest \[[@B48],[@B49]\]. Using this epigenetic silencing strategy, we were able to repress (≥90%) two genes encoding ISFs (ISF1, EHI_138480 and ISF2, EHI_025710) that were highly induced gene upon L-cysteine deprivation (Figure [6A](#F6){ref-type="fig"}). However, we could not repress the third highly induced gene (MFS; EHI_173950). Repression of ISF2, but not of ISF1, showed slight growth deflects when cultured in normal medium. However, a severe growth defect in ISF2-repressed, and relatively mild growth defect in ISF1-repressed G3 trophozoites were observed in L-cysteine-deprived medium (Figure [6B](#F6){ref-type="fig"}). We also checked if repression of ISF1 or 2 also affects the tolerance of trophozoites to H~2~O~2~mediated cytotoxicity. However, no significant difference in the tolerance to H~2~O~2~cytotoxicity was observed (Figure [6C](#F6){ref-type="fig"}). L-Cysteine deprivation induced growth defects in ISF1- and 2-repressed G3 trophozoites suggest that in addition to their proposed roles in combating oxidative stress, ISF1 and 2 proteins may also play important roles under L-cysteine deprivation. These ISF are very similar to bacterial NADPH-dependent FMN reductases, which are induced upon sulfate or L-cysteine starvation \[[@B50]\]. In *Escherichia coli*, this enzyme, called a two-component alkanesulfonate monooxygenase, allows utilization of alkanesulfonates as sulfur sources under sulfate or cysteine starvation \[[@B29]\]. However, it still remains unclear whether ISFs in *Entamoeba*are also involved in similar processes.

![**Epigenetic repression of iron sulfur flavoproteins in *E. histolytica*G3 strain**. ***A***) Semi-quantitative RT-PCR analysis of *ISF1*and *ISF2*expression levels in G3 parasites transfected with either empty vector (psAP2Gunma) or gene silencing plasmids (psAP2G-*ISF1*and psAP2G-*ISF2*). cDNA from these cell lines (psAP2G, *ISF*1gs, *ISF2*gs) were subjected to 30 cycles of PCR using specific primers for *ISF1*or *ISF2*. RNA polymerase was used as a control. PCR from samples without RT served as controls to exclude the possibility of genomic DNA contamination. ***B***) Effect of *ISF1*or *ISF2*repression on the growth of trophozoites cultured under normal (\"Normal\") or L-cysteine-depleted (\"CysDep\") conditions. ***C***) Effect of *ISF1 or ISF2*repression on the tolerance of amoebic trophozoites to oxidative stress.](1471-2164-12-275-6){#F6}

Conclusions
===========

This study represents the first genome-wide analysis of transcriptional changes induced by L-cysteine deprivation in protozoan parasites, and in eukaryotic organisms where L-cysteine represents the major intracellular thiol. We showed global changes in the expression of genes implicated in metabolism, signalling, oxidative defence, DNA/RNA regulation, and transport. Although a large number of genes were modulated upon L-cysteine deprivation, significant transcriptional changes in genes involved in SAA metabolism were not observed, which confirmed that changes in the metabolic flux across SAA metabolism are not caused by the changes in the expression of corresponding genes. Similarly, we also showed that the changes in the gene expression induced by L-cysteine deprivation are not shared by those induced by oxidative or nitrosative stress. The most important changes that occurred upon L-cysteine deprivation were the induction of iron sulfur flavoproteins and major facilitator super-family transporter. Repression of ISF1 and 2 genes caused growth defects under L-cysteine-deprived conditions. Further studies on the kinetic and biochemical analysis of ISFs and MFS transporter, and their regulation should help to better understand the physiological role of these proteins in the biology of *E. histolytica*. L-Cysteine depletion mediated time-dependent changes in the expression of RENTs suggest that similar to other eukaryotic cells, NMD may also be functional in *E. histolytica*. This study also confirmed that most of the L-cysteine deprivation-mediated metabolomic changes in amino acid, central energy, and phospholipid metabolism are not associated with the changes in the expression of the corresponding genes. This general lack of correlation between metabolome, proteome, and transcriptome appears to be a general characteristic in various organisms including *E*. *histolytica*, indicating that they have more complex mechanisms of expression regulation.

Methods
=======

Microorganism and cultivation
-----------------------------

Trophozoites of the *E. histolytica*clonal strain HM1: IMSS cl 6 and G3 strain, kindly provided by David Mirelman, Weisman Institute, Israel \[[@B48],[@B49]\], were maintained axenically in Diamond\'s BI-S-33 medium at 35.5°C as described previously \[[@B51],[@B52]\]. Trophozoites were harvested in the late-logarithmic growth phase for 2-3 days after inoculation of one-thirtieth to one-twelfth of the total culture volume. After the cultures were chilled on ice for 5 min, trophozoites were collected by centrifugation at 500 × g for 10 min at 4°C and washed twice with ice-cold PBS, pH 7.4.

RNA isolation and Affymetrix microarray hybridization
-----------------------------------------------------

Trophozoites were first grown in normal culture medium containing a high concentration of L-cysteine (8 mM) for approximately 24 hrs. After culture medium was replaced with the one containing no exogenous L-cysteine, culture was continued for the next 3, 6, 12, 24, or 48 h. Total RNA was isolated from harvested trophozoites using Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.) according to the manufacturer\'s protocol. The RNA was quantified and checked for purity by comparison of absorbance at 260 and 280 nm in the NanoDrop Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Integrity of isolated RNA was verified by using Bio-Rad\'s automated electrophoresis system Experion (RNA StdSens analysis kit). All reagents and protocols followed those described in the Affymetrix manuals. Briefly, total RNA (5 μg) was reverse transcribed using T7-Oligo (dT) primer in the first strand cDNA synthesis. After second strand synthesis, the double-stranded cDNA template was used for in vitro transcription, in the presence of biotinylated nucleotides to produce labelled cRNA. The cRNA was purified, quantified, fragmented, and hybridized for 16 h at 45°C to custom-generated Affymetrix platform microarray (49-7875) with probe sets consisting of 11 probe pairs representing 9,327 *E. histolytica*(Eh_Eia520620F_Eh) and 12,385 *E. invadens*open reading frames (Eh_Eia520620F_Ei). After hybridization, the arrays were washed and stained with streptavidin-phycoerythrin using a GeneChip^®^Fluidics Station 450 (Affymetrix, Santa Clara, CA, USA), according to the recommendations of the manufacturer. After washing and staining, the GeneChip^®^arrays were then scanned using the Hewlett-Packard Affymetrix Scanner 3000 (Affymetrix, Santa Clara, CA, USA), and the probe intensities were extracted using Affymetrix^®^GeneChip^®^Command Console™(Affymetrix, Santa Clara, CA, USA).

Analysis of microarray data
---------------------------

A minimum of two arrays were used for each condition and each time point. Raw Mas5 gene expression data were imported into the GeneSpring GX 10.0.2 program and normalized expression values for each probe set were obtained from raw probe intensities in R 2.7.0 (downloaded from the BioConductor project <http://www.bioconductor.org>) using robust multiarray averaging with correction for oligosequence (gcRMA). Standard correlation coefficients were calculated using GeneSpring GX 10.0.2. One way ANOVA analysis with Tukey\'s post hoc test was performed to extract differentially expressed genes. The p-values were calculated using Welch\'s test, and were corrected by Benjamini-Hochberg method.

Quantitative real-time PCR
--------------------------

Total RNA from the trophozoites cultured in either normal or L-cysteine-deprived medium was extracted as described above. cDNA was synthesized from 5 μg of total RNA using Superscript III First-Strand Synthesis System, and oligo(dT)~20~primer (Invitrogen). PCR was performed with the resulting cDNA as a template and specific oligonucleotide primers using the ABI PRISM 7300 Sequence Detection System (Applied Biosystems, Weiterstadt, Germany). A list of primers for qRT-PCR is shown in Additional file [6](#S6){ref-type="supplementary-material"}. Parameters for PCR were: an initial step of denaturation at 95°C for 9 min followed by 40 cycles of denaturation at 94°C for 30 s, annealing at 50°C for 30 s and extension at 65°C for 1 min. A final step at 95°C for 9 s, 60°C for 9 s and 95°C for 9 s was used to remove primer dimers \[[@B34]\].

Creation of *E. histolytica*transformants where expression of the genes induced upon L-cysteine deprivation were repressed
--------------------------------------------------------------------------------------------------------------------------

In order to construct plasmids for epigenetic silencing of *ISF1*, *ISF2*, and *MFS*, a fragment corresponding to a 420-bp long 5\' end of open reading frame of *ISF1*, *ISF2*and *MFS*genes was amplified by PCR from cDNA using sense and antisense oligonucleotides containing *StuI*and *SacI*restriction sites, respectively. A list of these primers is provided in Additional file [7](#S7){ref-type="supplementary-material"}. These PCR amplified products were digested with *StuI*and *SacI*, and ligated into the *StuI-*and *SacI*-double digested psAP-2-Gunma shuttle vector.

psAP-2-Gunma was constructed as follows. 5\'ap-a fragment were amplified from psAP-2 \[[@B48],[@B49]\], as a template, using sense and antisense oligonucleotides containing appropriate restriction sites at the 5\' end, with 5\'-AGCTCTAGA**ccgcgg**CGGCTTGCTGCACCCTTTG-3\' primer and 5\'-CTCT*gagctc*GAGCTCGTTTAA[aggcct]{.ul}CATGATTGTTTGTAAGATAT G-3\' primers (*SacII, SacI, and StuI*restriction sites are shown by bold-, italicized-, or underlined-text). PCR product and psAP-2 vector were digested by *SacI*and *SacII*. Digested PCR product was ligated into psAP-2 to yield psAP-2-Gunma vector (psAP2G).

*StuI-*and *SacI*-digested PCR products corresponding to a 420-bp long 5\' end of open reading frame of *ISF1*, *ISF2*and *MFS*genes were ligated into psAP-2-Gunma to construct gene silencing plasmids of target genes (psAP2G-*ISF1*, psAP2G-*ISF2*, and psAP2G-*MFS*). The trophozoites of *G3*strain were transformed with either empty vector or silencing plasmids by liposome-mediated transfection as previously described \[[@B11]\]. Transformants were initially selected in the presence of 1 μg/ml geneticin (Invitrogen), and the geneticin concentrations were gradually increased to 7 μg/mL during the subsequent two weeks prior to subjecting the transformants to analyses. The expression of the respective genes was confirmed by semi-quantitative RT-PCR as described previously \[[@B23]\]. These transformants were named as psAP2G (control) or -ISF1gs, ISF2gs, and MFSgs.

Growth assay of *E. histolytica*trophozoites
--------------------------------------------

Approximately 6 × 10^4^exponentially growing trophozoites of *E*. *histolytica*G3 strain transformed with psAP2G-*ISF1*, psAP2G-*ISF2*, or psAP2G (control) plasmid were inoculated in 6 ml of normal or L-cysteine-deprived BI-S-33 medium containing 7 μg/mL geneticin, and the parasites were counted every 24 h on a haemocytometer.

Assay of hydrogen peroxide sensitivity
--------------------------------------

To examine sensitivity to H~2~O~2~, *E. histolytica*G3 trophozoites harbouring psAP2G-*ISF1*, psAP2G-*ISF2*, or psAP2G were seeded into a 96-well plate (10^4^trophozoites per well) in BI-S-33 medium containing 7 μg/mL geneticin and incubated for 12-16 h at 35.5°C. The cells were then exposed to varying concentrations (0.8-6.4 mM) of H~2~O~2~for 1 h in the same culture medium. Following incubation, medium was removed and 100 μL pre-warmed Opti-MEM^®^I (Invitrogen) containing 10% (v/v) Cell Proliferation Reagent WST-1 (Roche Diagnostics, Mannheim, Germany) was added. After 1 h of incubation at 35.5°C, the optical density at *A*~450~was measured with that at *A*~595~as a reference using a microplate reader (Model 550, Bio-Rad, Tokyo, Japan). The initial density and incubation period of the cultures were chosen to maintain the control trophozoites in the late-logarithmic growth phase throughout the experiment, and also to allow the measurement of optical density in the linear portion of the curves. The assays were performed 3 times in triplicate.
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###### Additional file 1

**All transcriptomic data analyzed in this study**. Normalized average raw data (signal intensity), their converted data (in log~2~), and present call (P, present; M, marginal; A, absent) of the duplicates of all the probe sets at 0, 3, 6, 12, 24, and 48 h of L-cysteine deprivation are shown. Fold changes of expression relative to 0 h, and up/down-regulation of expression, as well as p-value and corrected p-value of ANOVA are also shown.
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###### Additional file 2

**List of genes induced ≥3 fold at one or more time points upon L-cysteine deprivation**. Probe ID, corrected p-value by ANOVA, fold change and up/down-regulation, and normalized expression levels in log~2~scale at each time point are shown. Locus ID, accession numbers, annotations, and other information related to GO term, InterProScan domains are shown.
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###### Additional file 3

**List of genes down-regulated ≥3 fold at one or more time points upon L-cysteine deprivation**. Probe ID, corrected p-value by ANOVA, fold change and up/down-regulation, and normalized expression levels in log~2~scale at each time point are shown. Locus ID, accession numbers, annotations, and other information related to GO term, InterProScan domains are shown.
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###### Additional file 4

**List of changes in expression of genes that are involved in sulfur-containing amino acid metabolism upon L-cysteine deprivation**. Normalized average raw data (signal intensity), their converted data (in log~2~), and present call (P, present; M, marginal; A, absent) of the duplicates of all the probe sets at 0, 3, 6, 12, 24, and 48 h of L-cysteine deprivation are shown. Fold changes of expression relative to 0 h, and up/down-regulation of expression, as well as p-value and corrected p-value of ANOVA are also shown.
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###### Additional file 5

**List of 41 genes modulated ≥3 fold by L-cysteine deprivation and also modulated ≥3 fold by oxidative (1 mM of H~2~O~2~for 1 h) and/or nitrosative stress (200 μM of DPTA-NONOate for 1 h)**. The list contains genes shown in Figure [3B](#F3){ref-type="fig"}.
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###### Additional file 6

**List of primers used for qRT-PCR**.
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###### Additional file 7

**List of primers used for the construction of plasmids for the repression of genes that were induced upon L-cysteine deprivation**.
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